Sign in

You're signed outSign in or to get full access.

Trier Bryant

About Trier Bryant

Independent director of Athena Technology Acquisition Corp. II (ATEK) since 2021; age 40 in 2024 and 39 in 2023. Background spans senior HR/DEI leadership and talent acquisition across technology and finance, with earlier service as a U.S. Air Force officer; B.S. in Systems Engineering with minors in Spanish and Leadership from the U.S. Air Force Academy. Serves on ATEK’s Audit Committee (financially literate) and Nominating & Corporate Governance Committee; classified as independent under NYSE American and SEC rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Alloy Therapeutics (82VS)General Partner & President (venture creation arm)Previously (dates not specified)Supported innovators launching drug discovery companies
AstraFirst Chief People OfficerMar 2020 – Jan 2021Built HR function for aerospace company building low-orbit rockets
SigFigVP of People & Workplace ExperienceApr 2019 – Mar 2020Led people operations at a global FinTech
TwitterGlobal Head of Revenue, G&A, University, and Diversity RecruitingFeb 2016 – May 2018Led recruiting across corporate functions and diversity
Goldman SachsVP Global Diversity Talent Acquisition; Chief of Staff to Global Head of Talent Acquisition2013 – 2016; Chief of Staff 2013–2014Built diversity talent pipelines and supported TA leadership
U.S. Air ForceOfficer2006 – 2013Pentagon-requested DEI and talent development initiatives for USAFA, USAF, DoD

External Roles

OrganizationRoleTenure/StartNotes
TrierBryant.comFounderNot specifiedAdvises organizations on workplace culture
Just Work LLCCo-founderNot specifiedProfessional services firm
Pathfinder 1963 LLCFounderFeb 2019DEI/HR consulting firm
Campaign ZeroBoard MemberNot specifiedNon-profit focused on ending police violence
Athena SPACsBoard MemberNot specifiedBoard role referenced across Athena SPAC franchise

Board Governance

  • Board class: Class I director; term to expire at the 2026 Annual Meeting; served since 2021 .
  • Independence: Determined independent under NYSE American/SEC rules; independent directors are a majority of the Board .
  • Executive sessions: Non-management directors meet in regular executive sessions per Corporate Governance Guidelines .
  • Leadership structure: Combined CEO/Chair; CEO Isabelle Freidheim serves as Chair, with rationale disclosed .
CommitteeBryant RoleChairEngagement
Audit CommitteeMemberSharon Brown‑HruskaFinancially literate; Audit Committee met 6 times in 2022 and 4 times in 2023
Nominating & Corporate GovernanceMember (appointed July 2024)Judith RodinCommittee did not meet in 2023; purposes include director screening, governance guidelines, board self‑evaluation
Compensation CommitteeNot a memberJudith Rodin (since July 2024)Compensation Committee did not meet in 2023; composition changed in July 2024
Attendance MetricFY 2022FY 2023
Board/Committee attendance (threshold disclosure)Each director attended at least 75% of Board and committee meetings Each director attended at least 75% of Board and committee meetings; five of six directors attended the 2023 annual meeting

Fixed Compensation

ComponentAmount/TermsPeriod
Cash retainer (non‑employee director)None; no cash compensation paid to directors prior to initial business combination
Committee feesNone disclosed prior to initial business combination
Meeting feesNone disclosed prior to initial business combination
Reimbursement of expensesSponsor, officers, directors reimbursed for out‑of‑pocket expenses; reviewed quarterly by Audit Committee; paid from funds outside trust
Administrative Services Agreement (Sponsor)$10,000 per month for office space/utilities/admin support to Sponsor
Sponsor Payments under Administrative Services AgreementFY 2022FY 2023H1 2024
Paid/Incurring Status$130,000 paid $120,000 paid by Dec 31, 2023 $60,000 incurred; $40,000 paid as of June 30, 2024

Performance Compensation

Equity Awards (RSUs/PSUs/Options)FY 2022FY 2023FY 2024
Non‑employee director grantsNone disclosed prior to initial business combination None disclosed prior to initial business combination None disclosed prior to initial business combination
  • No performance metrics, vesting schedules, or change‑of‑control provisions disclosed for directors prior to an initial business combination .

Other Directorships & Interlocks

EntityTypeRoleInterlock/Conflict Note
Athena Technology Sponsor II LLCSponsorSponsor holds ~88.4% of outstanding Class A Common Stock; Isabelle Freidheim is managing member with voting/investment discretionSponsor’s control can approve proposals unilaterally; affiliate of certain Board members and management; indicates governance concentration risk
ATEK BoardPublic companyIndependent Director (Class I)Combined CEO/Chair structure; independent director majority; committee independence confirmed

Expertise & Qualifications

  • HR/DEI leadership across Twitter and Goldman Sachs; people leadership at SigFig and Astra; venture company building at Alloy Therapeutics’ 82VS .
  • U.S. Air Force officer experience with Pentagon‑requested DEI/talent initiatives; B.S. Systems Engineering (minor in Spanish and Leadership) from USAFA .
  • Financially literate per Audit Committee composition; not designated audit committee financial expert (experts are Brown‑Hruska and Trabuco) .

Equity Ownership

MetricAs of Nov 18, 2024As of Aug 21, 2025
Shares outstanding (Class A)11,122,781 (includes 10,150,293 issued & outstanding + 972,488 underlying private units; 0 Class B) 10,145,156 Class A; 0 Class B
Trier Bryant beneficial ownership (shares)— (no shares reported) — (no shares reported)
Approximate % of outstanding
  • Anti‑hedging policy applies to directors, officers, employees, and controlled entities (prohibits hedging/monetization transactions) .

Governance Assessment

  • Independence and committee engagement: Bryant is independent and serves on Audit and Nominating & Governance; Audit Committee met 6x in 2022 and 4x in 2023, reflecting engagement; Nominating & Governance did not meet in 2023, which is a process rigor shortfall .
  • Attendance: Threshold disclosure indicates she met at least 75% attendance for Board/committees in 2022 and 2023; five of six directors attended the 2023 annual meeting, supporting baseline engagement .
  • Ownership alignment: No reported personal beneficial ownership for Bryant in 2024 or 2025; absence of director equity grants pre‑business combination limits “skin‑in‑the‑game” alignment typical in SPACs .
  • Control concentration and potential conflicts: Sponsor controls ~88.4% of Class A shares and can unilaterally approve proposals; administrative services and working capital loans to Sponsor create related‑party exposure subject to Audit Committee review—indicative of governance concentration risk and reliance on sponsor arrangements .
  • Board structure: Combined CEO/Chair is a governance risk flag for some investors due to reduced independent oversight; mitigants include independent committee chairs and executive sessions of non‑management directors .

RED FLAGS

  • Sponsor control (~88.4%) enabling unilateral approval of director elections and charter amendments .
  • Combined CEO/Chair structure .
  • Nominating & Governance Committee did not meet in 2023 .
  • No director equity ownership or grants pre‑business combination, limiting direct alignment .

Overall signal: Bryant’s independence and Audit Committee participation are positives, but ownership non‑alignment and sponsor control concentration pose governance risks to investor confidence until a de‑SPAC transaction establishes a conventional board/compensation structure .